Suppr超能文献

奥尔霍恩闪烁试验:可能性与局限性。其在视神经炎诊断、鉴别诊断、疾病进程监测及口服泼尼松龙疗效评估中的应用。

The Aulhorn flicker test: possibilities and limits. Its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease, and assessing the effect of oral prednisolone.

作者信息

Trauzettel-Klosinski S

机构信息

Department of Pathophysiology of Vision and Neuroophthalmology, University Eye Clinic, Tübingen, Federal Republic of Germany.

出版信息

Ger J Ophthalmol. 1992;1(6):415-23.

PMID:1490141
Abstract

The Aulhorn flicker test, which measures subjective brightness in relation to flicker frequency, is of high specificity (98%) and sensitivity (85.5%) in active optic neuritis (ON). The test has proved to be valuable in the diagnosis and differential diagnosis of ON and in monitoring the course of the disease. The first part of this paper gives an overview based on more than 10 years of experience and on the evaluation of more than 1000 eyes, 250 of them with active ON. The possibilities and limits of the test are analyzed. The second part of the paper presents new results of a prospective, randomized, and controlled treatment study. The Aulhorn flicker test was used to determine whether a prednisolone effect would be assessable by means of this subtle parameter. A total of 50 patients were treated orally with either methylprednisolone (100 mg/day initially) or vitamin B1 (100 mg/day), 38 of them in a double-blind fashion. Although a trend toward faster recovery in favor of prednisolone treatment was noted, no long-term benefit was observed after 1 year.

摘要

奥尔霍恩闪烁试验用于测量与闪烁频率相关的主观亮度,在活动性视神经炎(ON)中具有较高的特异性(98%)和敏感性(85.5%)。该试验已被证明在ON的诊断、鉴别诊断以及疾病进程监测方面具有重要价值。本文第一部分基于10多年的经验以及对1000余只眼睛(其中250只患有活动性ON)的评估给出了概述。分析了该试验的可能性和局限性。本文第二部分展示了一项前瞻性、随机对照治疗研究的新结果。使用奥尔霍恩闪烁试验来确定是否可以通过这个细微参数评估泼尼松龙的疗效。共有50例患者口服甲泼尼龙(初始剂量为100 mg/天)或维生素B1(100 mg/天)进行治疗,其中38例采用双盲方式。尽管注意到了有利于泼尼松龙治疗的更快恢复趋势,但1年后未观察到长期益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验